搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 7 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
Tottenham vs Arsenal Predictions and Betting Tips: Spurs have a chance to spoil Arsenal’s title ...
Goal.com· 3 日前All odds are courtesy of Betway, correct at the time of publishing and subject to change. ...
Tottenham vs Arsenal Predictions and Betting Tips: Spurs have a chance to spoil Arsenal’s title ...
Goal.com· 3 日前It also means that Spurs will have well-rested players who should be up for a crucial north ...
Social Media Digest
China Daily· 6 日前Earlier this month, an internet user named "Shiduopili" on Douyin, the Chinese version of TikTok, announced that she had ...